AGER and Alzheimer disease: RAGE, a 35kD transmembrane receptor of the immunoglobulin super family, was initially identified and characterized for its ability to bind advanced glycosylation end products (AGEs), but also other ligands such as Aβ, with implication in AD pathogenesis [92].